JPH0848616A - Hair tonic - Google Patents
Hair tonicInfo
- Publication number
- JPH0848616A JPH0848616A JP6204273A JP20427394A JPH0848616A JP H0848616 A JPH0848616 A JP H0848616A JP 6204273 A JP6204273 A JP 6204273A JP 20427394 A JP20427394 A JP 20427394A JP H0848616 A JPH0848616 A JP H0848616A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- hair
- acid derivative
- present
- duke
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000001256 tonic effect Effects 0.000 title abstract 3
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 claims abstract description 14
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims abstract description 12
- 235000002566 Capsicum Nutrition 0.000 claims abstract description 9
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical class OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000001390 capsicum minimum Substances 0.000 claims abstract description 9
- 229940098465 tincture Drugs 0.000 claims abstract description 9
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical class O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 8
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 claims abstract description 7
- 150000001875 compounds Chemical class 0.000 claims abstract description 7
- 229930007845 β-thujaplicin Natural products 0.000 claims abstract description 7
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims abstract description 6
- ILKBHIBYKSHTKQ-UHFFFAOYSA-N Diisopropylamine dichloroacetate Chemical compound OC(=O)C(Cl)Cl.CC(C)NC(C)C ILKBHIBYKSHTKQ-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229940084113 diisopropylamine dichloroacetate Drugs 0.000 claims abstract description 6
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims abstract description 6
- 150000002948 pantothenic acids Chemical class 0.000 claims abstract description 6
- 150000003712 vitamin E derivatives Chemical class 0.000 claims abstract description 6
- 240000008574 Capsicum frutescens Species 0.000 claims abstract 3
- 239000002537 cosmetic Substances 0.000 claims description 17
- 229940008396 carrot extract Drugs 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 19
- 235000020710 ginseng extract Nutrition 0.000 abstract description 9
- 150000001996 bisabolol derivatives Chemical class 0.000 abstract description 6
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 244000067456 Chrysanthemum coronarium Species 0.000 abstract 3
- 235000007871 Chrysanthemum coronarium Nutrition 0.000 abstract 3
- 241001071795 Gentiana Species 0.000 abstract 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 28
- 230000003779 hair growth Effects 0.000 description 13
- 239000000203 mixture Substances 0.000 description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- 241000208293 Capsicum Species 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 201000004384 Alopecia Diseases 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 230000003658 preventing hair loss Effects 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- -1 ester compounds Chemical class 0.000 description 3
- 230000003676 hair loss Effects 0.000 description 3
- 208000024963 hair loss Diseases 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 210000004761 scalp Anatomy 0.000 description 3
- 210000001732 sebaceous gland Anatomy 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- XBLVHTDFJBKJLG-UHFFFAOYSA-N Ethyl nicotinate Chemical compound CCOC(=O)C1=CC=CN=C1 XBLVHTDFJBKJLG-UHFFFAOYSA-N 0.000 description 2
- 206010020880 Hypertrophy Diseases 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 240000004371 Panax ginseng Species 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 2
- 206010068168 androgenetic alopecia Diseases 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- YNBADRVTZLEFNH-UHFFFAOYSA-N methyl nicotinate Chemical compound COC(=O)C1=CC=CN=C1 YNBADRVTZLEFNH-UHFFFAOYSA-N 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- GZIFEOYASATJEH-VHFRWLAGSA-N δ-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-VHFRWLAGSA-N 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- 239000001500 (2R)-6-methyl-2-[(1R)-4-methyl-1-cyclohex-3-enyl]hept-5-en-2-ol Substances 0.000 description 1
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- 238000011735 C3H mouse Methods 0.000 description 1
- DFERZTIWCDQJHJ-AXDSSHIGSA-N CCOC(=O)C(C(C)=O)CNC(=O)[C@H](O)C(C)(C)CO Chemical compound CCOC(=O)C(C(C)=O)CNC(=O)[C@H](O)C(C)(C)CO DFERZTIWCDQJHJ-AXDSSHIGSA-N 0.000 description 1
- 208000019300 CLIPPERS Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- IELOKBJPULMYRW-NJQVLOCASA-N D-alpha-Tocopheryl Acid Succinate Chemical compound OC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C IELOKBJPULMYRW-NJQVLOCASA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- GZIFEOYASATJEH-UHFFFAOYSA-N D-delta tocopherol Natural products OC1=CC(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-UHFFFAOYSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241001071861 Lethrinus genivittatus Species 0.000 description 1
- ILRKKHJEINIICQ-OOFFSTKBSA-N Monoammonium glycyrrhizinate Chemical compound N.O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ILRKKHJEINIICQ-OOFFSTKBSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- QSYCTARXWYLMOF-CBAPKCEASA-N N-[(R)-pantothenoyl]-L-cysteine Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)N[C@@H](CS)C(O)=O QSYCTARXWYLMOF-CBAPKCEASA-N 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 241000967294 Swertia japonica Species 0.000 description 1
- OFUHPGMOWVHNPN-QWZFGMNQSA-N [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] (9z,12z)-octadeca-9,12-dienoate Chemical compound O1[C@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CCC2=C(C)C(OC(=O)CCCCCCC\C=C/C\C=C/CCCCC)=C(C)C(C)=C21 OFUHPGMOWVHNPN-QWZFGMNQSA-N 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 230000002280 anti-androgenic effect Effects 0.000 description 1
- 239000000051 antiandrogen Substances 0.000 description 1
- 229940030495 antiandrogen sex hormone and modulator of the genital system Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 208000021930 chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids Diseases 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229940099418 d- alpha-tocopherol succinate Drugs 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 235000010389 delta-tocopherol Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- ODDPJZYHUSALPS-WUJWULDRSA-N ethyl 2-[[[(2R)-2,4-dihydroxy-3,3-dimethylbutanoyl]amino]methyl]-3-oxo-3-phenylpropanoate Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCC(C(=O)OCC)C(=O)C1=CC=CC=C1 ODDPJZYHUSALPS-WUJWULDRSA-N 0.000 description 1
- 229940064982 ethylnicotinate Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- 230000003662 hair growth rate Effects 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229960001238 methylnicotinate Drugs 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- WNIFXKPDILJURQ-JKPOUOEOSA-N octadecyl (2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@](C(=O)OCCCCCCCCCCCCCCCCCC)(C)C[C@H]5C4=CC(=O)[C@@H]3[C@]21C WNIFXKPDILJURQ-JKPOUOEOSA-N 0.000 description 1
- PXQPEWDEAKTCGB-UHFFFAOYSA-N orotic acid Chemical compound OC(=O)C1=CC(=O)NC(=O)N1 PXQPEWDEAKTCGB-UHFFFAOYSA-N 0.000 description 1
- DJWYOLJPSHDSAL-ROUUACIJSA-N pantethine Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO DJWYOLJPSHDSAL-ROUUACIJSA-N 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
- 239000002446 δ-tocopherol Substances 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、育毛効果、脱毛予防効
果に優れた養毛化粧料に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a hair nourishing cosmetic composition excellent in hair-growth effect and hair loss prevention effect.
【0002】[0002]
【従来の技術および発明が解決しようとする課題】従来
より、トウガラシチンキおよびニコチン酸誘導体等の血
行促進物質、また毛髪の栄養成分であるアミノ酸および
ビタミン類を配合してなる養毛化粧料が知られている。
さらには、皮脂腺の肥大防止効果をもつ成分や、男性ホ
ルモンの抑制作用をもつ成分を配合する医療用養毛剤や
養毛化粧料も数多く提案されている。BACKGROUND OF THE INVENTION Hair nourishing cosmetics containing a blood circulation promoting substance such as capsicum tincture and a nicotinic acid derivative, and amino acids and vitamins which are nutritional components of hair have been known. Has been.
In addition, a large number of medical hair nourishing agents and hair nourishing cosmetics containing a component having an effect of preventing sebaceous gland hypertrophy and a component having an inhibitory effect on male hormones have been proposed.
【0003】しかし、従来より使用されている血行促進
物質は、皮膚刺激が強くその配合量に制限があったり、
血行促進の持続時間が短かいという欠点がある。また、
毛髪の栄養成分も低濃度では皮膚への浸透性が低く、か
つ単独では効果が十分に発揮されないという問題点があ
る。However, the blood circulation-promoting substances that have been conventionally used have strong skin irritation and have a limited amount to be mixed,
It has a shortcoming that the duration of blood circulation promotion is short. Also,
There is a problem that the nutritional component of hair has low permeability to the skin at a low concentration, and the effect cannot be sufficiently exerted by itself.
【0004】ところで、男性型脱毛症は男性ホルモンの
過剰作用が原因の一つと言われているが、血行の不良や
毛母細胞の活性低下、皮脂腺の肥大化、頭皮の線維化等
の現象が複雑に絡みあって生じていると推察されてい
る。By the way, male pattern baldness is said to be caused by an excessive action of androgen, but phenomena such as poor blood circulation, decreased activity of hair matrix cells, hypertrophy of sebaceous glands, and fibrosis of scalp are caused. It is presumed that they are complicatedly intertwined.
【0005】しかし、男性ホルモンの過剰作用が原因と
いわれる毛母細胞の活性低下や皮脂腺の肥大化を抑制す
るために、単に男性ホルモン剤等を育毛剤として用いて
も、育毛作用を発現するまでには至らないのが現状であ
る。また、毛母細胞賦活剤や血行促進剤を単独で用いて
も、良好な成績は得られない。However, in order to suppress the decrease in the activity of hair mother cells and the enlargement of the sebaceous glands, which are said to be caused by the excessive action of male hormones, even when male hormone agents are simply used as hair-growing agents, until the hair-growing action is exhibited. It is the current situation that it does not reach. Moreover, even if a hair matrix activating agent or a blood circulation promoting agent is used alone, good results cannot be obtained.
【0006】前記の問題点を解決する手段として、特開
平5−58850号公報、特開平5−1399336号
公報、特開平5−170625号公報等を始めとして数
多くの養毛・育毛剤が提案されているが、末梢血流を促
進し、毛母細胞の賦活化をする物質を単独で用いても格
段の育毛作用については見出せなかった。As means for solving the above-mentioned problems, a large number of hair nourishing and hair-growth agents have been proposed, including JP-A-5-58850, JP-A-5-1399336 and JP-A-5-170625. However, even if a substance that promotes peripheral blood flow and activates hair matrix cells is used alone, no remarkable hair-growth effect was found.
【0007】本発明者らは、このような実情に鑑み、頭
皮の末梢血流の促進および毛母細胞の賦活化のある物質
について、鋭意研究を重ねた結果、センブリエキス、朝
鮮ニンジンエキス、デュークエキス、トウガラシチン
キ、ジイソプロピルアミンジクロロアセテート、γ−ア
ミノ酪酸、ヒノキチオール、ビタミンE誘導体、パント
テン酸誘導体、ニコチン酸誘導体、グリチルリチン酸誘
導体等の有効成分と、ビサボロールの水素添加体を同時
に含有した養毛化粧料が、相乗効果により、優れた養
毛、育毛効果を発現することを見いだし、本発明を完成
した。[0007] In view of such circumstances, the inventors of the present invention have conducted extensive studies on substances that promote peripheral blood flow in the scalp and activate hair matrix cells. As a result, the assembly extract, ginseng extract, and duke Hair nourishing makeup containing an active ingredient such as extract, capsicum tincture, diisopropylamine dichloroacetate, γ-aminobutyric acid, hinokitiol, vitamin E derivative, pantothenic acid derivative, nicotinic acid derivative, glycyrrhizic acid derivative, and hydrogenated bisabolol at the same time. The present invention has been completed by finding that the materials exhibit excellent hair-growth and hair-growth effects by a synergistic effect.
【0008】[0008]
【課題を解決するための手段】すなわち本発明は、セン
ブリエキス、朝鮮ニンジンエキス、デュークエキス、ト
ウガラシチンキ、ジイソプロピルアミンジクロロアセテ
ート、γ−アミノ酪酸、ヒノキチオール、ビタミンE誘
導体、パントテン酸誘導体、ニコチン酸誘導体、グリチ
ルリチン酸誘導体からなる群より選択された1種以上の
成分と、下記構造式化2[Means for Solving the Problems] That is, the present invention is to be used for the assembly extract, ginseng extract, duke extract, capsicum tincture, diisopropylamine dichloroacetate, γ-aminobutyric acid, hinokitiol, vitamin E derivative, pantothenic acid derivative, nicotinic acid derivative. And one or more components selected from the group consisting of glycyrrhizic acid derivatives and the following structural formula 2
【化2】 で示される化合物を含有することを特徴とする養毛化粧
料を提供するものである。Embedded image The present invention provides a hair nourishing cosmetic comprising a compound represented by:
【0009】以下、本発明の構成について詳述する。The structure of the present invention will be described in detail below.
【0010】本発明に用いられる、センブリエキスはセ
ンブリ(Swertia Japonica Makino)の開花期全草の乾燥
粉砕物をエタノールあるいいは含水エタノール中で温浸
し、ろ別して得られた抽出液である。The senburi extract used in the present invention is an extract obtained by digesting the dried and crushed whole plant of senburi (Swertia Japonica Makino) in ethanol or hydrous ethanol and filtering.
【0011】本発明に用いられる、朝鮮ニンジンエキス
は、オタネニンジン(Panax ginsengC.A.Meyer) の5〜
6年根乾燥細砕物をエタノールあるいは含水エタノール
中に冷浸し、ろ別して得られた抽出液である。The ginseng extract used in the present invention is 5 g of Panax ginseng C.A.Meyer.
It is an extract obtained by cold soaking the 6-year-old dried ground product in ethanol or hydrous ethanol and filtering.
【0012】本発明に用いられる、デュークエキスは、
ランジウムドメスティカムジャックバーデュークまたは
ランジウムドメスティカムジャックバーランサの果皮よ
り特開昭60−243020号公報に記載の方法により
得られる抽出物である。The duke extract used in the present invention is
It is an extract obtained from the skin of Randum domestica jack barduke or Randium domestica jack bar lancer by the method described in JP-A-60-243020.
【0013】本発明に用いられる、トウガラシチンキ、
ジイソプロピルアミンジクロロアセテート、γ−アミノ
酪酸、ヒノキチオールは通常の化粧品原料として使用さ
れている原料が使用出来る。Capsicum tincture used in the present invention,
As diisopropylamine dichloroacetate, γ-aminobutyric acid, and hinokitiol, raw materials used as usual cosmetic raw materials can be used.
【0014】本発明に用いられる、ビタミンE誘導体と
しては、フリーのビタミンE、またはビタミンEアセテ
ート、ビタミンEサクシネート、ビタミンEリノレー
ト、ビタミンEオロテート等のエステル化合物が典型的
な物質として使用出来る。ここで、ビタミンEはα−、
β−、γ−、δ−トコフェロールが何れも使用出来る。As the vitamin E derivative used in the present invention, free vitamin E or ester compounds such as vitamin E acetate, vitamin E succinate, vitamin E linoleate and vitamin E orotate can be used as typical substances. Where Vitamin E is α-,
Any of β-, γ-, and δ-tocopherol can be used.
【0015】本発明に用いられる、パントテン酸誘導体
としては、フリーのパントテン酸、パントテニルアルコ
ール、パントテニルエチルエーテル、アセチルパントテ
ニルエチルエーテル、ベンゾイルパントテニルエチルエ
ーテル、D−パンテサイン、D−パンテチン、D−パン
トテノイル−L−システイン、ジ−D−パントテノイル
−L−システイン等の一連の化合物が挙げられる。As the pantothenic acid derivative used in the present invention, free pantothenic acid, pantothenyl alcohol, pantothenyl ethyl ether, acetylpantothenyl ethyl ether, benzoylpantothenyl ethyl ether, D-panthesine, D-pantethine, Examples include a series of compounds such as D-pantothenoyl-L-cysteine and di-D-pantothenoyl-L-cysteine.
【0016】本発明に用いられる、ニコチン酸誘導体と
しては、ニコチン酸、ニコチン酸アミド、ニコチン酸−
α−トコフェロール、ニコチン酸ベンジル、ニコチン酸
メチル、ニコチン酸エチル等の化合物が使用出来る。As the nicotinic acid derivative used in the present invention, nicotinic acid, nicotinic acid amide, nicotinic acid-
Compounds such as α-tocopherol, benzyl nicotinate, methyl nicotinate and ethyl nicotinate can be used.
【0017】本発明に用いられる、グリチルリチン酸誘
導体としては、グリチルリチン酸、グリチルリチン酸ジ
カリウム、グリチルリチン酸モノアンモニウム、β−グ
リチルレチン酸、グリチルレチン酸ステアリル、等の化
合物が使用出来る。As the glycyrrhizic acid derivative used in the present invention, compounds such as glycyrrhizinic acid, dipotassium glycyrrhizinate, monoammonium glycyrrhizinate, β-glycyrrhetinic acid and stearyl glycyrrhetinate can be used.
【0018】本発明に用いられる、ビサボロールの水素
添加体は、前記構造式化2で示され、抽出法、製造法は
特に問わない。また、該化合物には立体異性体が存在す
るが、何れか単独または2種以上の混合物でも差し支え
ない。本化合物は、たとえば、α−ビサボロールをZ.
Naturforsch.,C:Biosci.,46
(5−6)、349−356(1991)に記載されて
いる、Hashidokoらの方法を用いて調製出来
る。本発明に用いるビサボロールの水素添加体を、以下
水添ビサボロールという。The hydrogenated product of bisabolol used in the present invention is represented by the above structural formula 2, and the extraction method and the production method are not particularly limited. Further, the compound has stereoisomers, but any one of them may be used alone or a mixture of two or more kinds may be used. This compound can be prepared, for example, by converting α-bisabolol into Z.
Natureforsch. , C: Biosci. , 46
(5-6), 349-356 (1991), can be prepared using the method of Hashidoko et al. The hydrogenated bisabolol used in the present invention is hereinafter referred to as hydrogenated bisabolol.
【0019】本発明に用いられる水添ビサボロールの配
合量は、特に限定されるものではないが、養毛化粧料の
総量を基準に0.01〜20重量%(以下、wt%と略
する)が好ましい。The amount of hydrogenated bisabolol used in the present invention is not particularly limited, but is 0.01 to 20% by weight (hereinafter abbreviated as wt%) based on the total amount of the hair nourishing cosmetic. Is preferred.
【0020】本発明に用いられる、センブリエキス、朝
鮮ニンジンエキスおよびデュークエキスの配合量は、養
毛化粧料の総量を基準として、乾燥残分に換算して、
0.001〜10.0wt%が好ましく、より好ましく
は0.01〜5.0wt%である。The amount of the assembly extract, ginseng extract and duke extract used in the present invention is converted into a dry residue based on the total amount of the hair nourishing cosmetic,
The amount is preferably 0.001 to 10.0 wt%, more preferably 0.01 to 5.0 wt%.
【0021】本発明に用いられる、トウガラシチンキ、
ジイソプロピルアミンジクロロアセテート、γ−アミノ
酪酸、ヒノキチオール、ビタミンE誘導体、パントテン
酸誘導体、ニコチン酸誘導体、グリチルリチン酸誘導体
の配合量は、養毛化粧料の総量を基準として、0.00
1〜5.0wt%が好ましく、より好ましくは0.01
〜2.0wt%である。Capsicum tincture used in the present invention,
The compounding amount of diisopropylamine dichloroacetate, γ-aminobutyric acid, hinokitiol, vitamin E derivative, pantothenic acid derivative, nicotinic acid derivative, glycyrrhizic acid derivative is 0.00 based on the total amount of the hair-care cosmetic.
1 to 5.0 wt% is preferable, more preferably 0.01
~ 2.0 wt%.
【0022】本発明の養毛化粧料は、常法に従って、た
とえばヘアートニック、ヘアーローション、ヘアークリ
ーム、ヘアーコンディショナー、シャンプー、リンス、
ヘアージェル、ヘアーミスト、ヘアーフォーム等の剤型
に製造し、使用することが可能である。The hair nourishing cosmetic composition of the present invention can be prepared according to a conventional method, for example, a hairnic, a hair lotion, a hair cream, a hair conditioner, a shampoo, a conditioner.
It can be manufactured and used in a dosage form such as hair gel, hair mist, and hair foam.
【0023】本発明の養毛化粧料は、養毛、育毛および
/または脱毛予防のために、それを目的とする局所(頭
皮)に、その剤型に従って塗布または噴霧して適用され
る。The hair nourishing cosmetic composition of the present invention is applied or sprayed to the intended topical region (scalp) for the purpose of hair nourishment, hair growth and / or hair loss prevention according to its dosage form.
【0024】なお、本発明の養毛化粧料には、色素、香
料、殺菌剤、防腐剤、角質溶解剤、抗アンドロゲン剤、
抗酸化剤等を本発明の目的を達成する範囲で適宜配合す
ることができる。The hair nourishing cosmetic composition of the present invention contains dyes, fragrances, germicides, preservatives, keratolytic agents, antiandrogens,
Antioxidants and the like can be appropriately added within a range that achieves the object of the present invention.
【0025】[0025]
【実施例】以下、実施例および比較例により本発明を詳
細に説明するが、本発明はこれらに限定されるものでは
ない。なお、本発明に使用した試験方法は下記の通りで
ある。The present invention will be described in detail below with reference to examples and comparative examples, but the present invention is not limited to these. The test method used in the present invention is as follows.
【0026】(1)マウス毛成長促進効果試験法 C3H系マウス(雄・8週齢・平均体重35g)の背部
中央の皮膚を電気バリカンで刈った後、シェーバーによ
り完全に除毛した。翌日より実施例および比較例の各試
料を被験部皮膚に毎日1回、一匹当り0.2ml塗布し
た。一試料に対して動物は一群10匹を使用した。な
お、対照群として基剤単独を塗布した。実験開始後14
日目に動物を屠殺し、被験部皮膚の写真撮影を行なっ
た。つぎに、写真を画像解析装置に取り込み、最初に毛
刈りした面積(A)と、発毛面積(B)を求め、さらに 発毛率(%)=〔(B)/(A)〕×100 を個々の動物について算出した。最後に、実施例または
比較例の各群の平均値を対照群の平均値により除した値
を毛成長促進効果として判定に用いた。(1) Test method for mouse hair growth promoting effect C3H mice (male, 8 weeks old, average weight 35 g) were shaved at the center of the back with electric clippers, and then completely shaved by a shaver. From the next day, 0.2 ml per animal of each sample of Example and Comparative Example was applied to the skin of the test site once daily. For each sample, 10 animals were used per group. The base alone was applied as a control group. 14 after the start of the experiment
On day one, the animals were sacrificed and the skin of the test area was photographed. Next, the photograph was taken into an image analysis device, and the area (A) where the hair was first shaved and the hair-growth area (B) were obtained, and the hair-growth rate (%) = [(B) / (A)] × 100 Was calculated for each animal. Finally, a value obtained by dividing the average value of each group of Examples or Comparative Examples by the average value of the control group was used for the determination as the hair growth promoting effect.
【0027】(2)実用試験法 男性型脱毛症患者20名の頭部に毎日朝夕2回、連続6
ケ月間試料を塗布した後の効果を評価した。試験結果
は、育毛効果、および脱毛予防効果の各項に対して、
「生毛が剛毛化した或は剛毛が増加した」、「脱毛が少
なくなった」と回答した人数で示した。(2) Practical test method The heads of 20 male pattern baldness patients were exposed to the head twice daily in the morning and evening, 6 times in a row.
The effect after applying the sample for a month was evaluated. The test results, for each item of hair growth effect and hair loss prevention effect,
The number of respondents who responded that "downy hair was bristled or bristles increased" and "hair loss decreased" was shown.
【0028】(3)各有効成分の製造法 実施例に用いるセンブリエキス、朝鮮ニンジンエキスお
よびデュークエキスの製造法に関しては特定されるもの
ではないが、各々の製造方法の概要を以下に記載する。
トウガラシチンキ、ヒノキチオール等の成分は、通常の
化粧品原料として用いられているものを試料とした。(3) Method for Producing Each Active Ingredient The method for producing the assembly extract, ginseng extract and duke extract used in the examples is not specified, but the outline of each method is described below.
As the components of capsicum tincture, hinokitiol, etc., those used as usual cosmetic raw materials were used as samples.
【0029】〔センブリエキスの製造法〕センブリ細砕
物50g を含水エタノール(エタノール50wt%)2
50mlに温度40〜50°Cで温浸した後、再び残さを
同様に温浸することをくり返し、抽出液1.5リットル
を得た。これを減圧濃縮した残留物に精製水を100ml
加え、一週間熟成した後、不溶部をろ別して得た抽出液
を減圧濃縮し、ついでエタノールを加えて抽出液のエタ
ノール含有量が50wt%になるように調整し、100
mlのセンブリエキスを得た。[Production method of assembly extract] 50 g of the assembly product was hydrous ethanol (ethanol 50 wt%) 2
After digestion in 50 ml at a temperature of 40 to 50 ° C., the residue was digested again in the same manner to obtain 1.5 liters of the extract. This was concentrated under reduced pressure and 100 ml of purified water was added to the residue.
In addition, after aging for 1 week, the extract obtained by filtering off the insoluble portion was concentrated under reduced pressure, and then ethanol was added to adjust the ethanol content of the extract to 50 wt%,
Obtained ml assembly extract.
【0030】〔朝鮮ニンジンエキスの製造法〕オタネニ
ンジンの5〜6年根乾燥細砕物50g を含水エタノール
(エタノール50wt%)200mlに1週間冷浸し、ろ
別して得られた抽出液のエタノールを留去し、精製水を
加えて抽出液のエタノール含有量が50wt%になるよ
うに調整し、さらにこれを7〜10週間冷所で熟成した
後、ろ別して100mlの朝鮮ニンジンエキスを得た。[Production method of Korean carrot extract] 50 g of dried ginseng roots of 5 to 6 years old were cold soaked in 200 ml of water-containing ethanol (50 wt% ethanol) for 1 week, and ethanol of the extract obtained by filtration was distilled off. Then, purified water was added to adjust the ethanol content of the extract to 50 wt%, and the extract was aged in a cold place for 7 to 10 weeks and then filtered to obtain 100 ml of a ginseng extract.
【0031】〔デュークエキスの製造法〕デュークエキ
スは、ランジウムドメスティカムジャックバーデューク
の果皮50g を粉砕し、エタノール200mlに浸し、1
週間室温に放置した。さらに、混合物をろ過し、減圧濃
縮して油状物質5.2g を得た。[Production Method of Duke Extract] Duke extract was prepared by crushing 50 g of the skin of Randium Domesticum Jack Burduke and immersing it in 200 ml of ethanol.
It was left at room temperature for a week. Further, the mixture was filtered and concentrated under reduced pressure to obtain 5.2 g of an oily substance.
【0032】以下本文中では、上記の如く50%エタノ
ール水溶液にて抽出して得られるエキスの純分(乾燥残
分で換算)を基準として配合量を表示する。In the following text, the compounding amount is indicated on the basis of the pure content of the extract obtained by extraction with the 50% aqueous ethanol solution as described above (calculated as the dry residue).
【0033】実施例1〜13、比較例1〜13(ヘアー
トニック) 表1の原料組成において、表2に記載の如く有効成分を
配合してヘアートニックを調製し、前記の諸試験を実施
した。なお、表中の%は重量%を示す。Examples 1 to 13 and Comparative Examples 1 to 13 (Heartonic) In the raw material composition of Table 1, the active ingredients were blended as shown in Table 2 to prepare a hairnic, and the above-mentioned tests were carried out. . In the table,% means% by weight.
【0034】[0034]
【表1】 [Table 1]
【0035】[0035]
【表2】 [Table 2]
【0036】(1)調製法 表1に記載の(B)成分を(A)成分中に溶解させた
後、(C)成分を添加し、混合攪拌分散して容器に充填
した。使用時には内容物を均一に振盪分散して使用し
た。(1) Preparation Method After dissolving the component (B) shown in Table 1 in the component (A), the component (C) was added, and the mixture was stirred and dispersed to fill a container. At the time of use, the content was uniformly dispersed by shaking before use.
【0037】(2)特性 各ヘアートニックの諸試験を実施した結果を表2に示し
た。表2の通り、比較例1〜13はマウス毛成長促進効
果およびヒト抜け毛改善効果が低く、実用試験の結果も
良好ではなかった。(2) Characteristics Table 2 shows the results of various tests conducted on each hairnic. As shown in Table 2, in Comparative Examples 1 to 13, the mouse hair growth promoting effect and the human hair loss improving effect were low, and the results of the practical test were also not good.
【0038】一方、実施例1〜13の本発明の養毛化粧
料は、高いマウス毛成長促進効果およびヒト抜け毛改善
効果を示し、さらに実用試験の結果も良好であり、諸試
験の全てにわたって明らかに良好な結果を示した。な
お、いずれの実施例の養毛化粧料を用いた場合にも、マ
ウスおよびヒトに炎症その他副作用と考えられる症状は
発現せず、本発明の養毛化粧料は安全性にも優れること
が明らかであった。On the other hand, the hair nourishing cosmetics of the present invention of Examples 1 to 13 show a high mouse hair growth promoting effect and a human hair loss improving effect, and the results of practical tests are also good. Showed good results. It should be noted that when using the hair nourishing cosmetic of any of the examples, no symptoms considered to be inflammation or other side effects are expressed in mice and humans, and it is clear that the hair nourishing cosmetic of the present invention is also excellent in safety. Met.
【0039】[0039]
【発明の効果】本発明の養毛化粧料は、毛母細胞の賦活
化作用を有し、育毛効果、脱毛予防効果および安全性に
優れる。EFFECTS OF THE INVENTION The hair nourishing cosmetic composition of the present invention has an activity of activating hair mother cells, and is excellent in hair growth effect, hair loss prevention effect and safety.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 C07C 31/133 9155−4H ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification code Internal reference number FI Technical indication C07C 31/133 9155-4H
Claims (1)
デュークエキス、トウガラシチンキ、ジイソプロピルア
ミンジクロロアセテート、γ−アミノ酪酸、ヒノキチオ
ール、ビタミンE誘導体、パントテン酸誘導体、ニコチ
ン酸誘導体、グリチルリチン酸誘導体からなる群より選
択された少なくとも1種以上の成分と、下記構造式 【化1】 で表される化合物を含有することを特徴とする養毛化粧
料。1. An assembly extract, a Korean carrot extract,
At least one component selected from the group consisting of Duke extract, capsicum tincture, diisopropylamine dichloroacetate, γ-aminobutyric acid, hinokitiol, vitamin E derivative, pantothenic acid derivative, nicotinic acid derivative, and glycyrrhizic acid derivative, and the following structure Formula [1] A hair nourishing cosmetic comprising a compound represented by:
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6204273A JP2774071B2 (en) | 1994-08-05 | 1994-08-05 | Hair restoration cosmetics |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6204273A JP2774071B2 (en) | 1994-08-05 | 1994-08-05 | Hair restoration cosmetics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0848616A true JPH0848616A (en) | 1996-02-20 |
| JP2774071B2 JP2774071B2 (en) | 1998-07-09 |
Family
ID=16487752
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP6204273A Expired - Fee Related JP2774071B2 (en) | 1994-08-05 | 1994-08-05 | Hair restoration cosmetics |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2774071B2 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1007036A4 (en) * | 1996-10-25 | 2001-02-28 | Univ Bar Ilan | METHODS OF USING BUTYRIC ACID OR BUTYRIC ACID DERIVATIVES TO PREVENT HAIR LOSS |
| JP2005200356A (en) * | 2004-01-16 | 2005-07-28 | Kanebo Cosmetics Inc | Hair restoration |
| US7404947B2 (en) * | 2002-12-19 | 2008-07-29 | Maria Grazia Canalini | Hair treatment lotion |
-
1994
- 1994-08-05 JP JP6204273A patent/JP2774071B2/en not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1007036A4 (en) * | 1996-10-25 | 2001-02-28 | Univ Bar Ilan | METHODS OF USING BUTYRIC ACID OR BUTYRIC ACID DERIVATIVES TO PREVENT HAIR LOSS |
| US7404947B2 (en) * | 2002-12-19 | 2008-07-29 | Maria Grazia Canalini | Hair treatment lotion |
| JP2005200356A (en) * | 2004-01-16 | 2005-07-28 | Kanebo Cosmetics Inc | Hair restoration |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2774071B2 (en) | 1998-07-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2977648B2 (en) | Hair restoration cosmetics | |
| JP2004091354A (en) | Hair tonic | |
| JP3014214B2 (en) | Hair restoration cosmetics | |
| JP3045613B2 (en) | Hair restoration cosmetics | |
| JPH0853327A (en) | Hair nourishing and hair-restoring agents using allantoin or its derivatives | |
| JP3464591B2 (en) | Hair restoration cosmetics | |
| JP4162823B2 (en) | Hair cosmetics | |
| JP2774071B2 (en) | Hair restoration cosmetics | |
| JP3133532B2 (en) | Hair restoration cosmetics | |
| JP2002080327A (en) | Hair grower | |
| WO2005076757A2 (en) | Hair and eyebrow, eyelashes growth stimulater | |
| JP2546813B2 (en) | Hair nourishing cosmetics | |
| JP3534959B2 (en) | Hair restoration cosmetics | |
| JP2994993B2 (en) | Hair restoration cosmetics | |
| JP3382148B2 (en) | External preparation for head | |
| JPH06145027A (en) | Hair tonic cosmetic | |
| JP3193544B2 (en) | Hair restoration cosmetics | |
| JP3014215B2 (en) | Hair restoration cosmetics | |
| JPH1077216A (en) | Hair-restoring cosmetic material | |
| JP2000016920A (en) | Hair tonic cosmetic | |
| JPS63196507A (en) | Hair nourishing cosmetic | |
| JP2955055B2 (en) | Hair restoration cosmetics | |
| JPS62103005A (en) | Hair tonic cosmetic | |
| JPH07291838A (en) | Hair tonic cosmetic | |
| JPS62255409A (en) | Hair tonic |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080424 Year of fee payment: 10 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090424 Year of fee payment: 11 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090424 Year of fee payment: 11 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100424 Year of fee payment: 12 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110424 Year of fee payment: 13 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120424 Year of fee payment: 14 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130424 Year of fee payment: 15 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130424 Year of fee payment: 15 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140424 Year of fee payment: 16 |
|
| LAPS | Cancellation because of no payment of annual fees |